RAECE FLYNT: Open Payments
NPI 1275148488 · ATHENS, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$267 in 12 payments from 5 companies in 2025. Trend: 2023 $444 · 2024 $310 · 2025 $267
Food & beverage: $267
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $90 |
| AstraZeneca Pharmaceuticals LP | 4 | $84 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $42 |
| Indivior Inc. | 1 | $30 |
| Otsuka America Pharmaceutical, Inc. | 1 | $21 |
Products named: Ozempic, BREZTRI, CAPLYTA, SUBLOCADE, Wegovy, AIRSUPRA, REXULTI, FARXIGA.
Industry payments across AL — which companies pay providers there.
